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Neither plasmid has proved amenable to physical isolation or analysis, and with the advent of recombinant D N A techniques it was decided to clone the OTC genes onto specifically developed cloning vectors.
Plasmid-cloning vectors
An initial search for small multicopy plasmids in various S . rimosus isolates was soon overtaken by the development of a series of broad host range plasmids at the John Innes Institute (Kieser et al., 1982) . The plasmid chosen was pIJ303, which carried the S. azureus gene for thiostrepton resistance. When this plasmid was transformed into S. rimosus and thiostrepton-resistance colonies selected, a low efficiency of transformation was observed. Plasmid D N A from the transformants was examined by agarose-gel electrophoresis, and found to be smaller in size than the original plasmid. This was interpreted as the result of restriction in uiuo. A 6.2 kb plasmid pPZ12 was selected for use as a cloning vector for S. rimosus. pPZ12 DNA extracted from S . rimosus was able to transform S. rimosus at normal frequencies ( -lo6/& without detectable modifications. The following unique sites are available for cloning: PstI, ClaI, KpnI and SacI.
When totally PstI-digested S. rimosus DNA was ligated into pPZl2 and transformed into an OTC-sensitive S . rimosus variant an OTC-resistant clone was isolated which contained an 8.7 kb insert. Southern-blotting analysis showed that this fragment was present in PstI-cut S. rimosus chromosomal DNA, but not present in DNA from the OTC-sensitive variant. This must, therefore, have suffered a deletion from the chromosome. Presumably at least some OTC biosynthetic genes must also have been lost or inactivated during the formation of such a variant; the continued production of OTC would have been suicidal.
In order to extend the cloned region, the 8.7 kb fragment was 32P-labelled by nick translation and used to probe genomic banks of S. rimosus in bacteriophage lambda or in Escherichia coli.
Chromosome 'walking'
The advantages of plaque hybridization in screening large numbers of clones lead us to clone S . rimosus D N A into the lambda vector L47.1. Size-selected (10-20kb) Suu3A-cut S . rimosus D N A was ligated into the BamHIgenerated arms and packaged in vitro. Plaques which hybridized with the probe were examined in more detail and three overlapping clones representing a total of 30-40kb from the OTC region were isolated. The inserts were subcloned into a Streptomyces plasmid as follows. We observed that the enzyme HindIII cuts S . rimosus DNA very infrequently, and that only one HindIII site exists in the cloned region. In the vector, however, there are HindIII sites just outside the Bam cloning sites. Treatment of the lambda clone DNA with HindIII therefore yielded a fragment representing the entire insert with small portions of lambda DNA at the ends. These fragments were ligated into a suitable plasmid vector, pPZ49. This was constructed by subcloning the erythromycin resistance gene from S. erythraeus into pPZ12. Cloning into the unique HindIII site causes insertional inactivation of the erythromycin resistance. Finally the plasmids were transformed into a restrictiondeficient strain of S. albus. This system provides a rapid method of cloning, screening by hybridization and subcloning.
Alternative methods for cloning S. rimosus D N A using bifunctional E. coli/Streptomyces plasmid and cosmid vectors have also been developed (Chambers & Hunter, 1984) . To facilitate the transformation of DNA into S . rimosus from other species of Streptomyces or from E. coli a simple procedure for the isolation of restriction-deficient mutants has been worked out (Hunter & Friend, 1984) . A total of 60kb of S. rimosus DNA from the OTC-resistance region has now been cloned using these methods.
Discussion
Rapid and efficient methods for cloning S . rimosus DNA have been developed and applied to one of the OTC biosynthetic regions. The way is now open to study the expression of the OTC biosynthetic genes and the regulation of OTC biosynthesis. As our understanding of gene expression increases we will for the first time be able to devise deliberate strategies for the construction of strains with increased antibiotic production rates. This holds primarily for the formation of the butyrate building unit. Aglycones of some 16-membered macrolides (e.g. magnamycin, tylosin, turimycin, platenolids, leukomycins, spiramycins) contain this unit. It was assumed that in case of magnamycin this unit is formed from succinic acid (Achenbach & Grisebach, 1964 (1967) assumed that this unit is formed from acetate.
Studies in which the biosynthesis of 16-membered macrolides was investigated by means of 3C-labelled precursors and nuclear magnetic resonance led Omura et al. (1977) to the conclusion that the significant randomization of isotopes in the aglycone moiety can be, at least partially, explained by oxidation of butyric acid to succinic acid which is further isomerized to methylmalonic acid (at the level of corresponding enzymes). After decarboxylation methylmalonic acid yields the propionate unit. Carboxylation of butyric acid gives rise to ethylmalonic acid which is isomerized, oxidized and decarboxylated yielding again methylmalonic acid, but, in this case, with an altered isotopic labelling (Omura & Nakagawa, 1981) . EthylmalonylCoA can only hardly be considered as a direct precursor of the butyrate unit as its absolute configuration is not known; in addition, the existence of both butyryl-CoA carboxylase and ethylmalonyl-CoA epimerase has not yet been demonstrated (Hutchinson et al., 1981) . Gersch et al. (1977) studying the biosynthesis of turimycin faced apparently different problems. Position 4' of the sugar mycarose of this antibiotic can be acylated by isovaleryl, propionyl, acetyl and iso-and n-butyryl. They degraded turimycin to mycarose and demycarosylturimycin but were not brave enough to conclude that ~-[U-~~C]valine might be a precursor of the butyrate unit of the lactone moiety. Reuter & Huttner (1976) reported that both theoretical considerations and experimental data give evidence against the direct synthesis of n-butyric acid from valine.
A similar situation with the biogenesis of the butyrate unit was observed when studying oligoketides of the polyether type (Dorman et al., 1976) . In studying the basic building units of narasin they came to the conclusion that enzymes of the producer, i.e. Streptomyces aureofaciens, are capable of the interconversion of propionate and butyrate. The mechanism of these interconversions is not clear. It cannot be explained by simple schemes of ci-and poxidation of basic building units. These authors were the first to demonstrate the conversion of propionate to butyrate.
Monensins A and B (differing only in a single butyrate and propionate unit) appear to be a highly valuable model which makes it possible to solve the origin of the butyrate unit. We found that Streptomyces cinnamonensis culture in a synthetic medium with L-valine produces predominantly monensin A, whereas in the presence 01 DL-leucine the synthesis of monensin B increases (Pospisil et al., 1982) .
When using radioactive substrates it is not necessary to degrade chemically the compounds under investigation but the differences in specific radioactivity between monensin A and monensin B can be directly related with the butyric acid unit of monensin A. On the basis of these experiments it could be concluded that L-valine and isobutyric acid are transformed to n-b_utyric acid which is a direct precursor of monensin A (Vanek et al., 1982) .
In studies using precursors labelled with the stable 13C it was clearly demonstrated that the butyrate unit of monensin A originates via a new metabolic pathway iccluding isomerization of isobutyrate to n-butyrate (Pospisil et al., 1983) .
The monensins A and B from S. cinnamonensis C-100-5 (non-pigmenting strain) were isolated and separated by preparative thin-layer chromatography. Labelled compounds were administered in three portions (1/2, 1/4, 1/4) at 24th, 48th and 72nd hour of the fermentation. The doses per 50ml flask were 17, 25, and 50mg of sodium [1-l3C]butyrate, [ l-13C]isobutyrate, and [ 1,2-l 3C,]acetate respectively.
As expected, C-15 of monensin A is predominantly labelled by sodium[ l-13C]butyrate; a lower level of enrichment was observed at C-1, -3, -5, -1 1, -1 7, -21, and -23, i.e. at carbons arising from C-1 of propionate. In monensin B only C-1 propionate sites (now also C-15) were labelled. Sodium-[ l-13C]isobutyrate produced the same incorporation pattern. Using double-labelled acetate, we found that five intact acetate units are incorporated into monensin B but seven into monensin A. The additional labelled carbons are those of butyrate origin.
The successful incorporation of isobutyrate into monensin A demonstrates a new metabolic pathway involving its isomerization to n-butyrate. Both isobutyrate and n-butyrate can be converted to propionate by S. cinnamonensis with the carboxyl label retained. Such an effect has already been observed in lysocellin, tylosin, and probably also in lasalocid A. Butyrate synthase participates in the biosynthesis of monensin A. This finding explains a higher than theoretical radioactivity found by Day et al. (1973) 
Our results show that in spite of simple building units, the biosynthesis of monensins is complex due mainly to multiple relationships among them.
Similar results were also reached by Omura et al. (1983) studying the formation of the butyrate unit in Streptomyces fradiae, a tylosin producer, and in Streptoverticillium kitasatoensis, producing leukomycin As, and thus confirmed the general validity of this new metabolic pathway.
Analyses of fatty acids in S. cinnamonensis showed (Rezanka et al., 1984) that iso-and anteiso-acids have a dominant representation. Iso-branching occurs most frequently in acids with an even number of carbon atoms while anteiso-branching is found in those acids having an odd number of carbons. The present results indicate that the amino acids participating in the biosynthesis of these fatty acids are mainly valine and isoleucine, while leucine does so to a much lesser extent (Table 1) .
The strain Streptomyces cinnamonensis C-100-5 produced roughly identical amounts of monensins A and B. In further studies we attempted to investigate the origin of the butyrate unit in strains producing predominantly monensin A. We used amino acid analogues of the group of aspartic acid and derived from pyruvic acid, i.e. 2-aminobutyrate, DLnorvaline, L-norleucine, 2-amino-3-chlorobutyrate, and, in addition, DL-ethionine, an inhibitor of transmethylation reactions (Pospisil et al., 1984) .
The usual procedures were applied. We verified the sensitivity of S. cinnamonensis to the antimetabolites in the presence of different carbon source and tested the effect of amino acids on the increased inhibitory role of m-norvaline and L-norleucine. After treatment with mutagens (u.v. light, NH,OH.HCl; survival 0.1-0.5%) the spore suspension was transferred to a liquid medium. The required concentrated solutions of the antimetabolites were added after a 4 2 h incubation which was continued for a further 72h. T h e results of these experiments are summarized in Table 2 . In the strains resistant to 2-amino-3-chlorobutyrate the production of monensin A varied from 85 to 90%. When investigating the excretion of amino acids into the synthetic culture medium valine (0.41 5pmol/ml) was detected in the strains resistant to 2-aminobutyrate and only traces of this amino acid were found in the 2-amino-3-chlorobutyrate-resistant strains. The strains also differed in the spectrum of other amino acids excreted into the culture medium, indicating that the regulation of the biosynthesis of the amino acids investigated in these strains is also different.
Therefore, in further experiments, we tried to prepare mutant strains of S. cinnamonensis resistant to 2-amino-3-chlorobutyrate and even to some other antimetabolites. These experiments were successful and stable mutant strains producing 95-97% of monensin A were obtained.
